Search research articles
Contact Us
Filters
Showing results (61-70 of 110) with videos related to
Page
of 11
Sort By:
Leukemia & Lymphoma
|
December 4, 2013
The clinical features, management and prognosis of primary and secondary indolent lymphoma of the bone: a retrospective study of the International Extranodal Lymphoma Study Group (IELSG #14 study)
Silvia Govi, David Christie, Silvia Mappa, et al.
Targeted Oncology
|
October 23, 2021
Avelumab in Combination Regimens for Relapsed/Refractory DLBCL: Results from the Phase Ib JAVELIN DLBCL Study
Eliza A Hawkes, Tycel Phillips, Lihua Elizabeth Budde, et al.
Journal of the National Cancer Institute
|
August 21, 2014
Risk of premature menopause after treatment for Hodgkin's lymphoma
Anthony J Swerdlow, Rosie Cooke, Andrew Bates, et al.
Blood
|
August 15, 2019
Pembrolizumab in relapsed or refractory Hodgkin lymphoma: 2-year follow-up of KEYNOTE-087
Robert Chen, Pier Luigi Zinzani, Hun Ju Lee, et al.
The New England Journal of Medicine
|
June 23, 2016
Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin's Lymphoma
Peter Johnson, Massimo Federico, Amy Kirkwood, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 26, 2017
Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma
Robert Chen, Pier Luigi Zinzani, Michelle A Fanale, et al.
British Journal of Haematology
|
May 22, 2020
Prognostic indices in diffuse large B-cell lymphoma in the rituximab era: an analysis of the UK National Cancer Research Institute R-CHOP 14 versus 21 phase 3 trial
Mary Gleeson, Nicholas Counsell, David Cunningham, et al.
British Journal of Haematology
|
September 1, 2017
Results of a multicentre UK-wide retrospective study evaluating the efficacy of brentuximab vedotin in relapsed, refractory classical Hodgkin lymphoma in the transplant naive setting
Toby A Eyre, Elizabeth H Phillips, Kim M Linton, et al.
British Journal of Haematology
|
September 17, 2013
A multicentre, phase II trial of ofatumumab monotherapy in relapsed/progressive diffuse large B-cell lymphoma
Bertrand Coiffier, John Radford, André Bosly, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
March 29, 2014
An integrated characterization of serological, pathological, and functional events in doxorubicin-induced cardiotoxicity
Laura Cove-Smith, Neil Woodhouse, Adam Hargreaves, et al.
Page
of 11
Search research articles
Search
Showing results (61-70 of 110) with videos related to
Sort By:
Page
of 11
Leukemia & Lymphoma
|
December 4, 2013
The clinical features, management and prognosis of primary and secondary indolent lymphoma of the bone: a retrospective study of the International Extranodal Lymphoma Study Group (IELSG #14 study)
Silvia Govi, David Christie, Silvia Mappa, et al.
Targeted Oncology
|
October 23, 2021
Avelumab in Combination Regimens for Relapsed/Refractory DLBCL: Results from the Phase Ib JAVELIN DLBCL Study
Eliza A Hawkes, Tycel Phillips, Lihua Elizabeth Budde, et al.
Journal of the National Cancer Institute
|
August 21, 2014
Risk of premature menopause after treatment for Hodgkin's lymphoma
Anthony J Swerdlow, Rosie Cooke, Andrew Bates, et al.
Blood
|
August 15, 2019
Pembrolizumab in relapsed or refractory Hodgkin lymphoma: 2-year follow-up of KEYNOTE-087
Robert Chen, Pier Luigi Zinzani, Hun Ju Lee, et al.
The New England Journal of Medicine
|
June 23, 2016
Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin's Lymphoma
Peter Johnson, Massimo Federico, Amy Kirkwood, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 26, 2017
Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma
Robert Chen, Pier Luigi Zinzani, Michelle A Fanale, et al.
British Journal of Haematology
|
May 22, 2020
Prognostic indices in diffuse large B-cell lymphoma in the rituximab era: an analysis of the UK National Cancer Research Institute R-CHOP 14 versus 21 phase 3 trial
Mary Gleeson, Nicholas Counsell, David Cunningham, et al.
British Journal of Haematology
|
September 1, 2017
Results of a multicentre UK-wide retrospective study evaluating the efficacy of brentuximab vedotin in relapsed, refractory classical Hodgkin lymphoma in the transplant naive setting
Toby A Eyre, Elizabeth H Phillips, Kim M Linton, et al.
British Journal of Haematology
|
September 17, 2013
A multicentre, phase II trial of ofatumumab monotherapy in relapsed/progressive diffuse large B-cell lymphoma
Bertrand Coiffier, John Radford, André Bosly, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
March 29, 2014
An integrated characterization of serological, pathological, and functional events in doxorubicin-induced cardiotoxicity
Laura Cove-Smith, Neil Woodhouse, Adam Hargreaves, et al.
Page
of 11